Where does Intrexon Actobiotics N.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Intrexon Actobiotics N.V. ranks #11,295 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Intrexon Actobiotics N.V. hold?

Intrexon Actobiotics N.V. holds 27 US utility patents granted between 2016 and 2025, spanning 12 technology areas.

What is Intrexon Actobiotics N.V.'s Innovation Score?

Intrexon Actobiotics N.V. has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Intrexon Actobiotics N.V. focus on?

Intrexon Actobiotics N.V.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 23 patents, ranking #848 of 6,058 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Intrexon Actobiotics N.V.'s patent grant rate increasing or decreasing?

Intrexon Actobiotics N.V.'s recent grant velocity is -15% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Intrexon Actobiotics N.V.'s patents?

Intrexon Actobiotics N.V.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Intrexon Actobiotics N.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Intrexon Actobiotics N.V.

USPTO PatentsView assignee record - 27 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Intrexon ranks #11,295 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 12 technology areas.

#11,295
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 23.1
avg claims per patent: -15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11295 · Foreign Corporation #11,295 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,295/49,997
PHOTO-FINISH INA Acquisition
CPC-FOCUS A61P · 12 areas
INNOV-PAR 40.3/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: INA Acquisition Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intrexon’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (29%) Velocity 2.7 pts (7%) Breadth 12.2 pts (30%) Claim depth 13.9 pts (34%)

Qualcomm Incorporated · highest

85
Centrexion Therapeut… · near

40
Alto-Shaam · near

40
Intrexon Actobiotics · this assignee

40
Prüftechnik Dieter… · near

40
Samsung Electro-Meha… · near

40
3D Lighting… · lowest

7

What this shows Intrexon's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Intrexon?

Each dot is one of Intrexon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intrexon’s own 23.1 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Intrexon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intrexon's grants concentrate

Intrexon Actobiotics N.V. is a focused PatentsView assignee: 12 CPC subclasses with 85.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2022. By volume, Intrexon sits between INA Acquisition Corp. and Industrial Revolution, Inc..

Intrexon's three-year grant acceleration

Intrexon Actobiotics N.V. shows 4 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

INA Acquisition

27
Infovision Optoel…

27
Inserm

27
Intradin (Shangha…

27
Ipgoal Microelect…

27
IQE

27
IQM Finland OY

27
Industrial Revolu…

27
Intrexon Actobiot… ◀

27

What this shows Intrexon holds 27 patents at rank #11,288, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Intrexon

By rank, the assignees closest to #11,288 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Intrexon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Intrexon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Intrexon ranks #848 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Alto-Shaam, Inc. 40 Samsung Electro-Mehanics Co., Ltd. 40 Prüftechnik Dieter Busch GmbH 40 Centrexion Therapeutics Corporation 40

Intrexon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Intrexon Actobiotics N.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	11.1%
2017	3	11.1%
2018	4	14.8%
2019	3	11.1%
2020	5	18.5%
2021	2	7.4%
2022	1	3.7%
2023	3	11.1%
2025partial year	3	11.1%

Which technologies does Intrexon Actobiotics N.V. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 23

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 21

C07K - Peptides 18

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 12

A23K - Fodder 10

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 9

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

C12Y - Enzymes 6

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 6

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 4

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 4

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Intrexon Actobiotics N.V.'s patent record in context - here's where to go next.

Intrexon Actobiotics N.V.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #11,295 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Intrexon Actobiotics N.V. against INA Acquisition Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.